ZENE
Celonova Biosciences, Inc.
Application Filed: 2013-03-12
Trademark Application Details
ABANDONED - NO STATEMENT OF USE FILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85873484 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Scott Woldow |
| Law Office Assigned | L30 |
| Employee Name | GRIFFIN, JAMES |
Timeline
| 2013-03-12 | Application Filed |
| 2013-11-26 | Published for Opposition |
| 2014-01-21 | Location: INTENT TO USE SECTION |
| 2015-02-23 | Abandon |
| 2015-02-23 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CELONOVA BIOSCIENCES, INC. |
| Address | 18615 TUSCANY STONE, SUITE 100 San Antonio DE 78258 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 37 |
| U.S. Codes: | 100,103,106 |
| Type Code | Type |
|---|---|
| GS0101 | Medical products, namely, embolic microspheres for use in endovascular therapy, for treatment of hypervascularized tumors and to control and prevent abnormal bleeding; Medical products, namely, embolic microspheres for embolization in the form of particles; Medical products, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical products, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical products, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical products, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical products, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical products, namely, embolic microspheres in the form of embolic particle implants; Medical products, namely, embolic microspheres for treating vascular anomalies of the body |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2013-03-15 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2013-03-15 | 2 NWOS I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2013-05-30 | 3 TCCA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2013-06-20 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2013-06-21 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2013-06-21 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2013-06-21 | 7 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2013-10-01 | 8 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2013-10-03 | 9 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2013-10-03 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2013-10-03 | 11 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2013-10-18 | 12 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2013-10-22 | 13 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2013-11-06 | 14 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2013-11-26 | 15 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2013-11-26 | 16 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2014-01-21 | 17 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2014-06-09 | 18 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2014-06-09 | 19 EXT1 S: |
| EXTENSION 1 GRANTED | 2014-06-09 | 20 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-06-11 | 21 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2015-02-23 | 22 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2015-02-23 | 23 MAB6 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ZENE 88130464 not registered Live/Pending |
Ever Glorious, Inc. 2018-09-25 |
 ZENE 85873484 not registered Dead/Abandoned |
CELONOVA BIOSCIENCES, INC. 2013-03-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 